ETHK Labs Inc. (HKG:1931)

Market Cap	1.96B -34.2%
Revenue (ttm)	3.37B +0.5%
Net Income	190.94M -33.1%
EPS	0.12 -44.6%
Shares Out	1.60B
PE Ratio	10.43
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,997,000
Average Volume	4,539,875
Open	1.180
Previous Close	1.180
Day's Range	1.160 - 1.260
52-Week Range	1.090 - 12.860
Beta	-0.52
RSI	37.64
Earnings Date	Mar 16, 2026

About ETHK Labs

ETHK Labs Inc., an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, After-sales Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, immunology, microbiology, and point-of-care testing. The company also provides haemostasis products; solution services to the cl...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1993
• Employees: 877
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1931

Financial Performance

In 2024, ETHK Labs's revenue was 3.16 billion, an increase of 2.40% compared to the previous year's 3.09 billion. Earnings were 260.42 million, an increase of 9.35%.

Financial numbers in CNY